| Ticker | ISIN | Type | Sector | Industry | Exchange | Country | Currency | Yield (%) | Yield 1Y (%) | Yield 3Y (%) | Yield 5Y (%) | Yield 10Y (%) | Dividend CAGR 1Y (%) | Dividend CAGR 3Y (%) | Dividend CAGR 5Y (%) | Growth Streak | Freq | P/E | Payout (%) | EPS | Market Cap | Book | P/B | Beta | Next Earnings | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() PHVS Pharvaris N.V. | NL00150005Y4 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -3.42 | 1.7B | 5.6694717 | 4.57 | -2.8 | N/A | ||||||
![]() TRVI Trevi Therapeutics, Inc. | US89532M1018 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -0.37 | 1.6B | 1.48 | 8.68 | 0.834 | N/A | ||||||
![]() FTRE Fortrea Holdings Inc. | US34965K1079 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -11.35 | 1.6B | 6.299 | 2.81 | 1.743 | N/A | ||||||
![]() DFTX Definium Therapeutics, Inc. | CA24477V1058 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | 0.0 | 1.6B | 1.701 | 9.78 | 0.22575912 | N/A | ||||||
![]() TSHA Taysha Gene Therapies, Inc. | US8776191061 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -0.33 | 1.6B | 0.799 | 7.30 | 1.036 | N/A | ||||||
![]() UPB Upstream Bio, Inc. | US91678A1079 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -6.4 | 1.6B | 7.011 | 4.20 | 0.0 | N/A | ||||||
![]() CAPR Capricor Therapeutics, Inc. | US14070B1017 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -1.75 | 1.6B | 1.834 | 15.76 | 0.614 | N/A | ||||||
![]() QURE uniQure N.V. | NL0010696654 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -4.58 | 1.6B | 3.68 | 6.85 | 0.588 | N/A | ||||||
![]() ORKA Oruka Therapeutics, Inc. | US00211Y4070 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0 | 1.6B | 10.0 | 3.21 | 0.0 | N/A | |||||||
![]() GLUE Monte Rosa Therapeutics, Inc. | US61225M1027 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 92.23 | 0.0% | 0.25 | 1.5B | 3.979 | 4.43 | 1.61 | N/A |